Medigene AG (MDG1) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.180x

Based on the latest financial reports, Medigene AG (MDG1) has a cash flow conversion efficiency ratio of -0.180x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.54 Million ≈ $-4.14 Million USD) by net assets (€19.66 Million ≈ $22.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medigene AG market cap and net worth for the company's overall valuation and market capitalisation.

Medigene AG - Cash Flow Conversion Efficiency Trend (2006–2023)

This chart illustrates how Medigene AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medigene AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medigene AG ranked by their cash flow conversion efficiency. Explore MDG1 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CAP-EX IRON ORE F:X0V	-0.025x
PALATIN TECHS DL-01 F:PTN	N/A
Antler Gold Inc V:ANTL	0.002x
Sparton Resources Inc V:SRI	-0.143x
WINDELN.DE SE INH O.N. F:WDL1	N/A
Sungmoon Electronics Co Ltd KO:014915	0.037x
Kridhan Infra Limited NSE:KRIDHANINF	-0.004x
Plantarc Bio Ltd TA:PLNT	-0.235x

Annual Cash Flow Conversion Efficiency for Medigene AG (2006–2023)

The table below shows the annual cash flow conversion efficiency of Medigene AG from 2006 to 2023. View MDG1 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	€21.07 Million ≈ $24.63 Million	€-15.12 Million ≈ $-17.68 Million	-0.718x	-321.90%
2022-12-31	€37.03 Million ≈ $43.29 Million	€11.98 Million ≈ $14.00 Million	0.323x	+234.79%
2021-12-31	€44.82 Million ≈ $52.39 Million	€-10.75 Million ≈ $-12.57 Million	-0.240x	+48.54%
2020-12-31	€53.15 Million ≈ $62.14 Million	€-24.79 Million ≈ $-28.98 Million	-0.466x	-132.33%
2019-12-31	€81.82 Million ≈ $95.66 Million	€-16.42 Million ≈ $-19.20 Million	-0.201x	-112.60%
2018-12-31	€107.42 Million ≈ $125.59 Million	€-10.14 Million ≈ $-11.86 Million	-0.094x	+60.98%
2017-12-31	€86.17 Million ≈ $100.74 Million	€-20.85 Million ≈ $-24.37 Million	-0.242x	-406.02%
2016-12-31	€78.59 Million ≈ $91.88 Million	€-3.76 Million ≈ $-4.39 Million	-0.048x	+59.43%
2015-12-31	€89.99 Million ≈ $105.21 Million	€-10.61 Million ≈ $-12.40 Million	-0.118x	+33.95%
2014-12-31	€49.07 Million ≈ $57.37 Million	€-8.76 Million ≈ $-10.24 Million	-0.178x	+47.14%
2013-12-31	€36.28 Million ≈ $42.41 Million	€-12.25 Million ≈ $-14.32 Million	-0.338x	-129.38%
2012-12-31	€44.22 Million ≈ $51.69 Million	€-6.51 Million ≈ $-7.61 Million	-0.147x	-202.77%
2011-12-31	€47.93 Million ≈ $56.04 Million	€6.86 Million ≈ $8.02 Million	0.143x	+151.20%
2010-12-31	€40.80 Million ≈ $47.70 Million	€-11.41 Million ≈ $-13.34 Million	-0.280x	+23.34%
2009-12-31	€51.87 Million ≈ $60.64 Million	€-18.93 Million ≈ $-22.13 Million	-0.365x	+13.45%
2008-12-31	€64.91 Million ≈ $75.88 Million	€-27.36 Million ≈ $-31.99 Million	-0.422x	-35.63%
2007-12-31	€103.09 Million ≈ $120.53 Million	€-32.04 Million ≈ $-37.46 Million	-0.311x	-2564.08%
2006-12-31	€108.51 Million ≈ $126.86 Million	€-1.27 Million ≈ $-1.48 Million	-0.012x	--

About Medigene AG

XETRA:MDG1 Germany Biotechnology

Market Cap

$2.30 Million

€1.97 Million EUR

Market Cap Rank

#30129 Global

#2615 in Germany

Share Price

€0.13

Change (1 day)

+0.00%

52-Week Range

€0.13 - €0.13

All Time High

€36.05